Actual results may vary materially from those expressed or implied by forward - looking statements based on a number
of factors, including, without limitation: (1) risks related to the consummation
of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated
time period, or at all, (b) the parties may fail to obtain shareholder approval
of the Merger Agreement, (c) the parties may fail to secure the termination or
expiration of any waiting period applicable under the HSR Act, (d) other conditions to the consummation
of the Merger under the Merger Agreement may not be satisfied, (e) all or part
of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination
of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee
of $ 74 million, or (c) the circumstances
of the termination, including the possible imposition
of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger; (3) the effects that the announcement or pendency
of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect
of limitations that the Merger Agreement places on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome
of pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A
of BWW's Annual
Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent
reports that BWW has filed or files with the SEC.
If it was not made against the insured during the policy period, then the insurer can disclaim coverage for that reason alone, regardless
of when the insured gave notice.1 If the claim was made during the policy period but the insured gave notice after the
expiration of the requisite
time frame for notice under the policy, then the ability to disclaim coverage will turn on whether the notice provisions are conditions precedent or covenants.2 This principle applies regardless
of whether the policy is a claims - made or a claims - made - and -
reported and
reported.3 If the notice provisions are covenants, then late notice constitutes a breach
of the policy by the insured, triggering application
of Md..
Coverage End Date - Your coverage ends on the earlier
of the following: 1) your return to your home country (except for Home Country Coverage); 2) the end
of the coverage period purchased; 3) the
expiration of 364 days from your coverage start date; 4) the date shown on your ID card; 5) when you are no longer eligible for coverage; 6) when the maximum benefit amount has been paid; 7) the date you request in writing that your coverage end; 8) the date you become a permanent residence
of your host country; 9) the date you
report for full -
time active duty in any armed forces.
• Skilled in drawing blood under special circumstances such as venous complications, having received training in complex blood drawing techniques • Adept at cleaning and sterilizing lab equipment and working area in accordance to department standards and quality control requirements • Experienced in performing patient phlebotomy at different locations, maintaining aseptic techniques during specimen collection, immediate labeling
of specimen, and prompt disposal
of needles / supplies in appropriate containers • Hands - on experience in preparing specimens for testing / shipping in accordance with hospital policy • Proficient at checking package integrity and
expiration dates for sterilized supplies • Adept at maintaining lab records which include conducting and
reporting lab tests and ordering documentation • Qualified to perform preventative and consistent maintenance
of department equipment • Demonstrated expertise in using specialized equipment in accordance Lab Standard operating Procedures • Skilled at preparing Reagents and Solutions accurately and when required by Lab Authorities • Documented success in completing inventories, entering supplies / specimens and quantity information on
time and with 100 % accuracy • Focused on ensuring all testing processes are in sync with preset laboratory protocols